St. Francis Cancer Center | St. Francis Cancer Center | NRG BR003
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1520
clinical-trial-template-default,single,single-clinical-trial,postid-1520,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

NRG BR003

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer. Read more> 

 

« Available Clinical Trials